Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Research Council grant · Running

MUSCAD Advanced analysis of multiparametric volumetric ultrafast ultrasound: a novel approach for non-invasive breast cancer diagnosis

Coordinator
Institut National De La Sante Et De La Recherche Medicale, France
Runs
1 January 2025 to 31 December 2029
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101164974

What the project is doing

In the project's own words, from its summary on CORDIS.

Tumour development follows a diversity of complementary biological pathways, including the modification of the tissue structure and vascularization, which are not currently captured by imaging techniques in the clinic. Breast cancer patients undergo a series of imaging sessions using complementary modalities, including ionizing mammographies. In many cases, this imaging is not precise enough for a diagnosis, so that tissue samples in the form of biopsies are used to further characterize the tumour and determine the appropriate treatment.

Beyond the pain and stress associated with biopsies, this complex process is costly and time consuming, and delays the time to diagnosis. Ultrasound B-mode imaging is largely used in the diagnostic process of breast cancer, in part because it is low cost, portable and largely available, as well as non-ionizing and non-invasive. Our laboratory, Institute Physics for Medicine Paris has recently developed several quantitative techniques allowing for the measurement of tissue stiffness, fiber organization, and vascular mapping, all relevant to tumour development.

In this project, I propose a new approach to diagnosing breast cancer non-invasively by applying machine learning analysis to rich volumetric multiparametric maps of complementary tumour aspects, obtained using these innovative ultrafast ultrasound techniques. The project will tackle the technological challenge of integrating these techniques into a common acquisition and analysis framework, and include the collection of a large clinical dataset and the development and validation of a predictive malignancy model informing on tumour characteristics for the diagnosis.

This approach will open the door to fully virtual biopsies, impacting society on a large scale in terms of cost, diagnostic efficacy, and patient comfort.

Topics

Who is involved

OrganisationCityCountryRole
Institut National De La Sante Et De La Recherche MedicaleParisFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI